| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2273 | 2019 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 535 | 2019 |
| The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery JM Isbell, RA Tamboli, EN Hansen, J Saliba, JP Dunn, SE Phillips, ... Diabetes care 33 (7), 1438-1442, 2010 | 325 | 2010 |
| Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity JP Dunn, RM Kessler, ID Feurer, ND Volkow, BW Patterson, MS Ansari, ... Diabetes care 35 (5), 1105-1111, 2012 | 187 | 2012 |
| Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings JP Dunn, RL Cowan, ND Volkow, ID Feurer, R Li, DB Williams, ... Brain research 1350, 123-130, 2010 | 182 | 2010 |
| Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy JP Dunn, NN Abumrad, I Breitman, PA Marks-Shulman, CR Flynn, ... Diabetes care 35 (1), 137-142, 2012 | 126 | 2012 |
| Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery EN Hansen, RA Tamboli, JM Isbell, J Saliba, JP Dunn, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 300 (5 …, 2011 | 96 | 2011 |
| Perspectives in gestational diabetes mellitus: a review of screening, diagnosis, and treatment JM Perkins, JP Dunn, SM Jagasia Clinical diabetes 25 (2), 57-62, 2007 | 74 | 2007 |
| Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes T Heise, JH DeVries, S Urva, J Li, EJ Pratt, MK Thomas, KJ Mather, ... Diabetes Care 46 (5), 998-1004, 2023 | 40* | 2023 |
| Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity SW Savage, DH Zald, RL Cowan, ND Volkow, PA Marks‐Shulman, ... Obesity 22 (6), 1452-1457, 2014 | 30 | 2014 |
| Tirzepatide for the treatment of obesity: rationale and design of the SURMOUNT clinical development program CW le Roux, S Zhang, LJ Aronne, RF Kushner, AM Chao, S Machineni, ... Obesity 31 (1), 96-110, 2023 | 29 | 2023 |
| Caloric restriction‐induced decreases in dopamine receptor availability are associated with leptin concentration JP Dunn, NN Abumrad, RM Kessler, BW Patterson, R Li, ... Obesity 25 (11), 1910-1915, 2017 | 13 | 2017 |
| Lipoprotein profiles in class III obese Caucasian and African American women with nonalcoholic fatty liver disease AE Garcia, N Kasim, RA Tamboli, RS Gonzalez, J Antoun, EA Eckert, ... PloS one 10 (11), e0142676, 2015 | 11 | 2015 |
| Choice of imaging modality in the assessment of coronary artery disease risk in extreme obesity JP Dunn, MM Huizinga, R See, WN Irani Obesity 18 (1), 1, 2010 | 10 | 2010 |
| Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme) A Kiyosue, JP Dunn, X Cui, A Hickey, T Hirase, T Imaoka, RJ Heine Diabetes, Obesity and Metabolism 25 (4), 1056-1067, 2023 | 8 | 2023 |
| Brief communication: β-cell function influences dopamine receptor availability JP Dunn, NN Abumrad, BW Patterson, RM Kessler, RA Tamboli Plos one 14 (3), e0212738, 2019 | 8 | 2019 |
| Management of Type 2 Diabetes After Bariatric Surgery JP Dunn, SM Jagasia Clinical Diabetes 25 (3), 112-114, 2007 | 8 | 2007 |
| Pseudohypobicarbonatemia in a patient presenting with suspected diabetic ketoacidosis JL Cartier, DC Look, JP Dunn AACE Clinical Case Reports 4 (2), 108-111, 2018 | 7 | 2018 |
| Striatal dopamine responses to feeding are altered in people with obesity SA Eisenstein, KJ Black, A Samara, JM Koller, JP Dunn, T Hershey, ... Obesity 28 (4), 765-771, 2020 | 6 | 2020 |
| Disminución de la disponibilidad del receptor de dopamina tipo 2 después de la cirugía bariátrica: hallazgos preliminares (2010) JP Dunn, RL Cowan, ND Volkow, R Li, RM Kessler, NN Abumrad Brain Res 1350, 123-30, 2010 | 3 | 2010 |
